Potential of human induced pluripotent stem cells in studies of liver disease-Reference-Cited by-同舟云学术

Potential of human induced pluripotent stem cells in studies of liver disease

Published:2015-02-10 Issue:1 Volume:62 Page:303-311
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sampaziotis Fotios¹,Segeritz Charis‐Patricia¹,Vallier Ludovic¹²

Affiliation:

1. Wellcome Trust Medical Research Council Cambridge Stem Cell Institute, Anne McLaren Laboratory for Regenerative Medicine and Department of SurgeryUniversity of CambridgeCambridge CB2 0SZ United Kingdom

2. Wellcome Trust Sanger InstituteHinxton Cambridge United Kingdom

Funder

Medical Research Council

European Research Council

European Commission

Children Disease Liver Fundation

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.27651

Reference61 articles.

1. GBD 2010: understanding disease, injury, and risk

2. AASLD practice guidelines: Evaluation of the patient for liver transplantation

3. Translation of Research Evidence From Animals to Humans

4. Assembly of Human Organs from Stem Cells to Study Liver Disease

5. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D organoid cultivation improves the maturation and functional differentiation of cholangiocytes from human pluripotent stem cells;Frontiers in Cell and Developmental Biology;2024-07-08

2. Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: Current perspectives and future challenges;Pharmacology & Therapeutics;2024-01

3. Reversal of liver failure using a bioartificial liver device implanted with clinical-grade human-induced hepatocytes;Cell Stem Cell;2023-05

4. Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations;Cellular and Molecular Gastroenterology and Hepatology;2023

5. Modelling urea cycle disorders using iPSCs;npj Regenerative Medicine;2022-09-26